Literature DB >> 26660192

Quantification of Free Phenytoin by Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS).

Judy Peat1, Clint Frazee1, Uttam Garg2.   

Abstract

Phenytoin (diphenylhydantoin) is an anticonvulsant drug that has been used for decades for the treatment of many types of seizures. The drug is highly protein bound and measurement of free-active form of the drug is warranted particularly in patients with conditions that can affect drug protein binding. Here, we describe a LC/MS/MS method for the measurement of free phenytoin. Free drug is separated by ultrafiltration of serum or plasma. Ultrafiltrate is treated with acetonitrile containing internal standard phenytoin d-10 to precipitate proteins. The mixture is centrifuged and supernatant is injected onto LC-MS-MS, and analyzed using multiple reaction monitoring. This method is linear from 0.1 to 4.0 μg/mL and does not demonstrate any significant ion suppression or enhancement.

Entities:  

Keywords:  Convulsions; Epilepsy; Free phenytoin; Mass spectrometry; Phenytoin; Seizures

Mesh:

Substances:

Year:  2016        PMID: 26660192     DOI: 10.1007/978-1-4939-3252-8_25

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Development and Validation of an LC-MS/MS Method and Comparison with a GC-MS Method to Measure Phenytoin in Human Brain Dialysate, Blood, and Saliva.

Authors:  Raphael Hösli; Stefan König; Stefan F Mühlebach
Journal:  J Anal Methods Chem       Date:  2018-04-01       Impact factor: 2.193

2.  A sensitive LC-MS/MS method for quantification of phenytoin and its major metabolite with application to in vivo investigations of intravenous and intranasal phenytoin delivery.

Authors:  Richard N Prentice; Mohammad Younus; Shakila B Rizwan
Journal:  J Sep Sci       Date:  2022-05-31       Impact factor: 3.614

Review 3.  New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (AEDs).

Authors:  Karina Sommerfeld-Klatta; Barbara Zielińska-Psuja; Marta Karaźniewcz-Łada; Franciszek K Główka
Journal:  Molecules       Date:  2020-11-02       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.